Maxwell Janosky is an Oncology physician affiliated with Englewood Hospital and Medical Center. OpenAlex indexes 18 publications with 305 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
350 Engle St
Berrie Bldg Floor 1
Englewood, NJ 076311808
Telephone
201-568-5250Registry record last updated 26 Nov 2014.
Industry payments
68 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202523 payments
- Daiichi Sankyo Inc.Program year202525 payments
- E.R. Squibb & Sons, L.L.C.Program year202520 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
30.2%Factor Xa inhibitor26.8%Eliquis61%Xarelto39%Part D≥24 patientsLow Molecular Weight Heparin3.3%Enoxaparin Sodium100%Part D<11 patientsCancer & immunology
28%Kinase inhibitor14.7%Lenvima31%Brukinsa27%Imbruvica21%Jakafi21%Part D<11 patientsAntimetabolite7.6%Hydroxyurea100%Part D≥11 patients+ 2 more classes in this area
Nervous system
15%Opioid Agonist9.7%Oxycodone Hcl37%Tramadol Hcl34%Oxycodone-Acetaminophen29%Part D<11 patientsGabapentinoids2.6%Gabapentin100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- CRE25-038: Worsening COPD From Hyperviscosity: A Case Report of Waldenström Macroglobulinemia
Journal of the National Comprehensive Cancer Network
2025 - Eccrine Carcinoma Mimicking Breast Cancer: Diagnostic Challenges and Hormone Therapy as an Emerging Treatment
Journal of Medical Cases
2025 - IMMUNE CHECKPOINT INHIBITOR-INDUCED MYOPERICARDITIS IN A PATIENT WITH NON-SMALL CELL LUNG CANCER: A COMPLICATION TO RECOGNIZE AND TREAT EARLY
Journal of the American College of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Minaxi Jhawer, MBBS
Englewood Hospital and Medical Center
Marc Arginteanu, MD
Englewood Hospital and Medical Center
Alfred Steinberger, MD
Englewood Hospital and Medical Center
Theresa Impeduglia, MD
Englewood Hospital and Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”